Search

Search Constraints

You searched for: Author/Creator Musella, Valeria

Search Results

2. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab. Issue 6 (4th March 2015)

3. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab. Issue 6 (4th March 2015)

4. Does therapy with biological drugs influence COVID‐19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone. Issue 6 (17th November 2020)

5. Dynamics of humoral and cellular immunity elicited by the BNT162b2 mRNA vaccine in psoriatic patients under targeted immunosuppression: A longitudinal cohort study. (3rd December 2022)

6. End-tidal carbon dioxide (ETCO2) and ventricular fibrillation amplitude spectral area (AMSA) for shock outcome prediction in out-of-hospital cardiac arrest. Are they two sides of the same coin?. (March 2021)

7. Mortality due to COVID-19 during the pandemic: A comparison of first, second and third SMAtteo COvid19 REgistry (SMACORE). Issue 2 (February 2022)

8. Subtype‐dependent prognostic relevance of an interferon‐induced pathway metagene in node‐negative breast cancer. Issue 7 (4th May 2014)

9. The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study. (September 2021)